ArticleScientific reports2026
Diagnostic efficacy of endoscopic ultrasound-guided fine needle aspiration cytology in pancreatic lesions.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopic Ultrasound (EUS) guided needle aspiration cytology (FNAC) is a rapid, reliable diagnostic procedure used in various benign and malignant pancreatic lesions. The present study was aimed to determine the diagnostic accuracy of endoscopic ultrasound-guided needle aspiration cytology (EUS-FNAC) in diagnosing pancreatic lesions. To the best of our knowledge, the first study of this kind in eastern India. The current study was a hospital-based prospective study. The study was conducted in a tertiary care hospital of eastern India over a period of two year. A total of 67 cases of radiologically detected pancreatic lesions were studied. Pancreatic lesions were sampled by EUS-FNA and cytology reporting was done basing on Papanicolaou Society for assessment of cytology of pancreatobiliary system (PSC)as well as new WHO system of reporting 2022. A simultaneous needle biopsy(FNAB)was done to reach at a final histopathology diagnosis. The Cytology reports were compared with the corresponding histology reports as the latter is considered to be the gold standard. Diff-Quik / PAP/H&E stains were routinely used for cytology, and H& E stain was used for corresponding histology sections. In morphologically challenging cases, immunohistochemistry was also done. The SPSS statistics software (version 16) was used for Statistical analysis. The study comprised a total of 67 pancreatic lesions cases with a mean age of 55.5 years and age range of 30–80 years. In both sexes, maximum cases were observed between 51 and 60 years. 42cases were males, whereas 25 cases were females (M: F = 1.7:1). The pancreatic head was the most involved site [29(43.28%) cases]. Among PSC categories; Category II (negative for malignancy) cases were highest in number(n = 27),then were the Category VI( positive or malignant ) i.e. (n = 25).Sensitivity, specificity, PPV, NPV and diagnostic accuracy were 84.6%, 60%, 58%, 85.71%&70.14% respectively. Whereas reanalysis done by WHO categories revealed; Sensitivity, specificity, PPV, NPV and diagnostic accuracy as87.5%, 82.8%, 82.3%, 87.8% &85.07%. EUS-FNA is an effective diagnostic procedure for differentiating malignant and benign pancreatic lesions. Hence, it is helpful for initiating an early management strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.